TorsinB is a member of the AAA+ (ATPases Associated with diverse cellular Activities) protein family, which is involved in various cellular processes including organelle biogenesis, protein quality control, and membrane trafficking. TorsinB Activators, if they were to be classified as a distinct chemical group, would comprise molecules capable of enhancing the biological activity of TorsinB either through direct molecular interactions or by influencing the cellular context in which TorsinB operates.
Direct TorsinB Activators would interact with the protein at key structural domains that are essential for its ATPase activity or substrate interaction. Such activators could bind to TorsinB and induce a conformational alteration that increases its affinity for ATP, thereby accelerating its enzymatic activity. They might also stabilize TorsinB in an active state or promote its interaction with essential cofactors and substrates necessary for its function. The binding of these activators could occur at allosteric sites, which are distinct from TorsinB's active sites, enabling the activators to potentiate the protein's activity without directly competing with natural substrates or ATP. Indirect TorsinB Activators would enhance the activity of TorsinB by modulating the expression levels of the protein or the signaling pathways that regulate its function. This could include small molecules that upregulate the transcription of the TorsinB gene or chemical compounds that inhibit the degradation pathways targeting TorsinB, such as the ubiquitin-proteasome system. Additionally, post-translational modifications, such as phosphorylation, could be induced by these activators, resulting in altered activity, stability, or interaction of TorsinB with other proteins within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker, reducing calcium influx into cells. TorsinB is sensitive to changes in calcium levels and this reduced influx can lead to enhanced functional activity of TorsinB. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is also a calcium channel blocker that reduces calcium influx into cells. Similar to verapamil, the reduction in calcium can enhance the functional activity of TorsinB. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Dantrolene is a ryanodine receptor antagonist that reduces calcium release from the endoplasmic reticulum. This reduction can enhance the functional activity of TorsinB. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that disrupts calcium homeostasis, increasing cytosolic calcium. This can enhance TorsinB activity, as TorsinB is sensitive to calcium levels. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Cyclopiazonic acid is a specific inhibitor of the SERCA pump, similar to thapsigargin. It disrupts calcium homeostasis, enhancing TorsinB activity. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine is a modulator of the ryanodine receptor. It can induce a long-lasting open state of the receptor, leading to increased cytosolic calcium and enhanced TorsinB activity. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB is an IP3 receptor antagonist that reduces calcium release from the endoplasmic reticulum. This reduction can enhance the functional activity of TorsinB. | ||||||
Tetracaine | 94-24-6 | sc-255645 sc-255645A sc-255645B sc-255645C sc-255645D sc-255645E | 5 g 25 g 100 g 500 g 1 kg 5 kg | $66.00 $309.00 $500.00 $1000.00 $1503.00 $5000.00 | ||
Tetracaine is a local anesthetic that blocks voltage-gated sodium channels, indirectly affecting calcium levels and enhancing TorsinB activity. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Similar to tetracaine, lidocaine is a local anesthetic that blocks voltage-gated sodium channels, indirectly influencing calcium levels and enhancing TorsinB activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that reduces cytosolic calcium levels, enhancing TorsinB activity. | ||||||